These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 30251159

  • 1. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 2. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 3. Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.
    Rock EM, Limebeer CL, Ward JM, Cohen A, Grove K, Niphakis MJ, Cravatt BF, Parker LA.
    Psychopharmacology (Berl); 2015 Oct; 232(20):3841-8. PubMed ID: 26297326
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 5. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 6. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
    Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Biol Psychiatry; 2007 Nov 15; 62(10):1103-10. PubMed ID: 17511970
    [Abstract] [Full Text] [Related]

  • 8. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S.
    Psychopharmacology (Berl); 2009 Jul 15; 204(4):607-16. PubMed ID: 19259645
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 15; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 15; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 11. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.
    Mazzola C, Medalie J, Scherma M, Panlilio LV, Solinas M, Tanda G, Drago F, Cadet JL, Goldberg SR, Yasar S.
    Learn Mem; 2009 May 15; 16(5):332-7. PubMed ID: 19403796
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V.
    Neuropharmacology; 2008 Jul 15; 55(1):85-93. PubMed ID: 18534634
    [Abstract] [Full Text] [Related]

  • 13. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B, Muccioli GG, Lambert DM.
    Br J Pharmacol; 2013 Jun 15; 169(4):794-807. PubMed ID: 22970888
    [Abstract] [Full Text] [Related]

  • 14. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB.
    J Psychopharmacol; 2019 May 15; 33(5):606-614. PubMed ID: 30789299
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
    Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D.
    CNS Drug Rev; 2006 May 15; 12(1):21-38. PubMed ID: 16834756
    [Abstract] [Full Text] [Related]

  • 16. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
    Zhou Y, Schwartz BI, Giza J, Gross SS, Lee FS, Kreek MJ.
    Psychopharmacology (Berl); 2017 Oct 15; 234(19):2955-2970. PubMed ID: 28730283
    [Abstract] [Full Text] [Related]

  • 17. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colin R.
    Eur J Pharmacol; 2007 May 07; 562(1-2):82-91. PubMed ID: 17336288
    [Abstract] [Full Text] [Related]

  • 18. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA, Xu Z, Mali SS, Hohmann AG.
    Pharmacol Res; 2019 Apr 07; 142():267-282. PubMed ID: 30739035
    [Abstract] [Full Text] [Related]

  • 19. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A, Gidyk DC, Diwan M, Gouveia FV, Lipsman N, Giacobbe P, Nobrega JN, Hamani C.
    Neuropharmacology; 2020 Apr 07; 166():107965. PubMed ID: 31962287
    [Abstract] [Full Text] [Related]

  • 20. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 07; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.